NEWTON, Mass., March 25, 2024 Lumicell Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer detection during surgery, highlights presentations from clinical studies examining the use of investigational LUMISIGHT™ (pegulicianine) in combination with Lumicell™ Direct Visualization System (DVS) at the Society of Surgical Oncology Annual Meeting in Atlanta, Georgia, March 20-23, 2024.
Experts find new treatment for breast cancer - China Daily » Capital News capitalfm.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalfm.co.ke Daily Mail and Mail on Sunday newspapers.
Neoadjuvant treatment with pegylated liposomal doxorubicin and cyclophosphamide, followed by a taxane, such as docetaxel or nab-paclitaxel, concomitant with trastuzumab and pertuzumab elicited responses in patients with HER2-positive breast cancer.
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.